Reverse Transcription at Low Deoxynucleotide Concentrations and Polymerase Chain Reaction Analysis Reveals the Molecular Role of Ribosomal Ribonucleic Acid 2’-O-Me Modification in Fibrillarin-deficient Colorectal Cancer Cells

that FBL is overexpressed and promotes tumor growth in breast cancer.FBL facilitates tumor growth and is related to poor prognosis in breast cancer.10 However, its role in CRC is unclear.In addition, FBL is involved in deoxyribonucleic acid (DNA) damage repair and cell cycle regulation as well.Its decreased expression can cause cell cycle defects and decreased translation efficiency.11 IntroductIonColorectal cancer (CRC), the third most prevalent malignancy around the world, has recently witnessed a noticeable increase in incidence.1 It still has a 5-year survival rate of around 60%, 2 which highlights the necessity of studying its pathogenesis.A hallmark of cancer cells is their metabolic addiction to hyperactive ribosome biogenesis.3 In the process of ribosome maturation, about 200 nucleotides of precursor ribosomal ribonucleic acid (pre-rRNA) are modified, such as by 2'-O-methylation (2'-O-Me) and pseudouridylation.This contributes to ribosomal heterogeneity and promotes oncogenesis.4 The fibrillarin (FBL) protein, which is highly conserved across eukaryotes and primarily localized to the nucleolus, is encoded by the FBL gene and exhibits high expression levels within this organelle.5 FBL is an important methyltransferase for rRNA 2'-O-Me in eukaryotes.Translational accuracy, the fidelity of ribosomal assembly, and the efficiency of protein synthesis are influenced by 2'-O-Me modification.6 Basic cellular processes are deeply affected by the aberrant expression or function of FBL.In mouse models, the inhibition or mutation of FBL blocks early embryonic development.In this case, cells are unable to divide and differentiate normally, which in turn influences normal embryo implantation and development.7 In zebrafish, aberrant FBL expression disrupts the neural differentiation process and leads to developmental malformations of the nervous system.8,9 Recent studies reveal 1-

Authors

Institutions

Publication Details

Journal
Journal of Postgraduate Medicine Education and Research
Published
2026-11-18
DOI
https://doi.org/10.5005/jp-journals-10028-1806
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
1.12
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reverse Transcription at Low Deoxynucleotide Concentrations and Polymerase Chain Reaction Analysis Reveals the Molecular Role of Ribosomal Ribonucleic Acid 2’-O-Me Modification in Fibrillarin-deficient Colorectal Cancer Cells

Yu-Sheng Qin, Fei Wu, Lihua Qiu
1 citations
Journal of Postgraduate Medicine Education and Research
RNA modifications and cancer
1.12
article

Reverse Transcription at Low Deoxynucleotide Concentrations and Polymerase Chain Reaction Analysis Reveals the Molecular Role of Ribosomal Ribonucleic Acid 2’-O-Me Modification in Fibrillarin-deficient Colorectal Cancer Cells

Yu-Sheng Qin, Fei Wu, Lihua Qiu
article en
1 citations

Abstract

that FBL is overexpressed and promotes tumor growth in breast cancer.FBL facilitates tumor growth and is related to poor prognosis in breast cancer.10 However, its role in CRC is unclear.In addition, FBL is involved in deoxyribonucleic acid (DNA) damage repair and cell cycle regulation as well.Its decreased expression can cause cell cycle defects and decreased translation efficiency.11 IntroductIonColorectal cancer (CRC), the third most prevalent malignancy around the world, has recently witnessed a noticeable increase in incidence.1 It still has a 5-year survival rate of around 60%, 2 which highlights the necessity of studying its pathogenesis.A hallmark of cancer cells is their metabolic addiction to hyperactive ribosome biogenesis.3 In the process of ribosome maturation, about 200 nucleotides of precursor ribosomal ribonucleic acid (pre-rRNA) are modified, such as by 2'-O-methylation (2'-O-Me) and pseudouridylation.This contributes to ribosomal heterogeneity and promotes oncogenesis.4 The fibrillarin (FBL) protein, which is highly conserved across eukaryotes and primarily localized to the nucleolus, is encoded by the FBL gene and exhibits high expression levels within this organelle.5 FBL is an important methyltransferase for rRNA 2'-O-Me in eukaryotes.Translational accuracy, the fidelity of ribosomal assembly, and the efficiency of protein synthesis are influenced by 2'-O-Me modification.6 Basic cellular processes are deeply affected by the aberrant expression or function of FBL.In mouse models, the inhibition or mutation of FBL blocks early embryonic development.In this case, cells are unable to divide and differentiate normally, which in turn influences normal embryo implantation and development.7 In zebrafish, aberrant FBL expression disrupts the neural differentiation process and leads to developmental malformations of the nervous system.8,9 Recent studies reveal 1-

Journal of Postgraduate Medicine Education and ResearchVol. 61(1)
Liuzhou Maternal and Child Health Hospital (CN), Liuzhou General Hospital (CN), Precision for Medicine (United States) (US)
Good health and well-being
Openalex Percentile: Top 31%
RNA modifications and cancer
1.12
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon